RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Pedro Ferchmin to Nicotinic Antagonists

This is a "connection" page, showing publications Pedro Ferchmin has written about Nicotinic Antagonists.
Connection Strength

0.669
  1. Ferchmin PA, P?rez D, Castro Alvarez W, Penzo MA, Maldonado HM, Eterovic VA. ?-Aminobutyric acid type A receptor inhibition triggers a nicotinic neuroprotective mechanism. J Neurosci Res. 2013 Mar; 91(3):416-25.
    View in: PubMed
    Score: 0.437
  2. Eterovic VA, Lu R, Eakin AE, Rodr?guez AD, Ferchmin PA. Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ. Cell Mol Neurobiol. 1999 Dec; 19(6):745-57.
    View in: PubMed
    Score: 0.176
  3. Eterovic VA, Hann RM, Ferchmin PA, Rodriguez AD, Li L, Lee YH, McNamee MG. Diterpenoids from Caribbean gorgonians act as noncompetitive inhibitors of the nicotinic acetylcholine receptor. Cell Mol Neurobiol. 1993 Apr; 13(2):99-110.
    View in: PubMed
    Score: 0.028
  4. Eterovic VA, Li L, Ferchmin PA, Lee YH, Hann RM, Rodriguez AD, McNamee MG. The ion channel of muscle and electric organ acetylcholine receptors: differing affinities for noncompetitive inhibitors. Cell Mol Neurobiol. 1993 Apr; 13(2):111-21.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support